cerebrovascular disorder: A disorder resulting from inadequate blood flow in the vessels that supply the brain. Representative examples include cerebrovascular ischemia, cerebral embolism, and cerebral infarction.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
4285 |
4. Check minimum number of eventsNone |
4285 |
5. Include endpointsNone |
4285 |
6. Filter based on genotype QC (FinnGen only) |
4285 |
Control definitions (FinnGen only)
- Control exclude
- I9_STR_EXH, I9_TIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I60-I69
- Name in latin
- Haemorrhagia subarachnoidalis
Similar endpoints
↥List of similar endpoints to
Subarachnoid haemorrhage
based on the number of shared cases.
Similar with more cases:
- Aneurysms, operations, SAH
- Nontraumatic intracranial haemmorrhage
- Stroke, including SAH
- Cerebrovascular diseases (FINNGEN)
- Cerebrovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 48665 | 24683 | 23067 |
| Only index persons | 28228 | 14996 | 13232 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.68 | 0.71 | 0.64 |
| Only index persons | 0.53 | 0.55 | 0.51 |
| Median age at first event (years) | |||
| Whole population | 56.90 | 58.99 | 54.65 |
| Only index persons | 56.20 | 57.69 | 54.52 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4285 | 2221 | 2064 |
| Unadjusted period prevalence (%) | 0.83 | 0.76 | 0.91 |
| Median age at first event (years) | 55.28 | 54.56 | 56.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3931
- Matched controls
- 39307
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
323.0
416
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
246.1
323.0
835
43
AA1AD
NOMESCO Finland
CT of head and brain
5.8
323.0
1759
4848
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
+∞
323.0
563
*
AAF00
NOMESCO Finland
Ventriculostomy
136.7
323.0
416
34
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
135.3
323.0
538
46
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
7924.6
323.0
672
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
+∞
323.0
434
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
4503599627370496.0
323.0
1855
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
40.2
323.0
576
167
2161
FHL
Neck ligation, big brain
1037.1
323.0
376
*
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
323.0
429
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
139.2
323.0
445
36
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
777.2
323.0
1038
18
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
42.5
323.0
528
143
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
110.7
323.0
511
53
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
15.8
297.8
505
363
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
339.5
251.3
252
8
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
857.4
248.7
242
*
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
+∞
247.5
235
*
43090
ICD-8 Finland
Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata
+∞
244.3
232
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
38.3
242.1
311
88
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
30.7
237.5
322
114
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
+∞
212.4
202
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.8
210.7
1058
3437
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
355.1
203.7
204
6
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
+∞
201.8
192
*
K90
ICPC
Stroke/cerebrovascular accident
22.4
193.4
287
138
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.1
185.2
487
769
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
21.0
181.8
275
140
43099
ICD-8 Finland
Subarachnoid haemorrhage, Without mention of hypertension
+∞
174.2
166
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
17.1
173.0
282
177
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
305.1
172.3
174
6
4309X
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]
+∞
172.1
164
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
51.9
171.5
207
42
N03AB02
ATC
phenytoin; systemic
21.3
171.4
258
129
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
108.4
170.7
186
18
ZXD05
NOMESCO Finland
Urgent procedure
2.7
166.3
1570
7734
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
+∞
157.3
150
*
XA800
NOMESCO Finland
Neuropsychological investigation
8.9
145.4
325
394
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
13.9
137.5
243
185
R51.80
ICD-10 Finland
Headache
3.5
134.7
715
2332
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
6.7
129.3
351
570
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
220.4
124.5
128
6
N03AX14
ATC
levetiracetam; systemic
9.7
120.4
254
277
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
88.9
115.8
129
15
AA5PD
NOMESCO Finland
CT examination of brain pefusion
71.7
115.3
132
19
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
204.4
115.2
119
6
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
12.4
113.5
211
179
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
169.1
109.9
115
7
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
15.4
104.5
176
119
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.1
103.5
267
401
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
7.2
102.6
261
384
K91
ICPC
Cerebrovascular disease
23.1
102.1
149
67
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
515.9
102.0
101
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
7.6
94.9
233
325
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
19.4
94.6
146
78
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
9.7
92.6
195
211
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
91.1
795
3519
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
80.6
90.6
102
13
N18
ICPC
Paralysis/weakness
11.1
90.1
176
165
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
84.6
796
3653
R4150
NOMESCO Finland
Neuropsychological rehabilitation
31.1
81.4
109
36
N03AF02
ATC
oxcarbazepine; oral
6.4
81.2
223
364
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
400.3
79.1
79
*
PA2AD
NOMESCO Finland
CT angiography of brain
28.9
78.4
107
38
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
165.3
77.3
81
5
ZXD35
NOMESCO Finland
Usual procedure
4.8
74.7
265
585
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
24.2
72.6
104
44
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
52.3
72.5
87
17
I60.5
ICD-10 Finland
Subarachnoid haemorrhage from vertebral artery
+∞
72.1
69
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
8.3
71.8
165
207
4373A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured
152.8
71.2
75
5
C08CA06
ATC
nimodipine; systemic
112.2
71.1
77
7
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
16.3
70.8
116
73
205
Kela drug reimbursment
Chronic hypertension
1.9
69.9
1342
8321
I63.8
ICD-10 Finland
Other cerebral infarction
125.6
69.1
74
6
B01AC04
ATC
clopidogrel; oral
2.4
68.6
649
2951
H53.4
ICD-10 Finland
Visual field defects
8.5
68.4
154
187
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
22.6
65.0
95
43
N03AF01
ATC
carbamazepine; oral, rectal
3.6
64.9
316
933
AA9CW
NOMESCO Finland
NA
81.5
64.2
72
9
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
62.5
350
1149
Z2445
NOMESCO Finland
Psychologist
5.4
62.1
194
371
I60
ICD-10 Finland
Subarachnoid haemorrhage
+∞
59.5
57
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
12.8
59.1
107
86
N03AG01
ATC
valproic acid; systemic, rectal
3.5
57.0
283
847
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
56.8
345
1198
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
51.1
49
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.0
51.1
214
554
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
7.3
51.0
126
177
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
49.5
235
678
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
14.3
48.9
84
60
PA7BD
NOMESCO Finland
CT angiography of neck and brain
8.8
47.0
103
120
43000
ICD-8 Finland
Subarachnoid haemorrhage, Post aneyrisma sacculare, cum hypertonia
+∞
47.0
45
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
45.3
602
3157
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
44.9
43
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
42.6
1187
8002
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
42.4
2312
18591
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
22.9
42.3
61
27
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
15.1
40.1
67
45
G45.3
ICD-10 Finland
Amaurosis fugax
41.3
39.4
49
12
R47.0
ICD-10 Finland
Dysphasia and aphasia
14.3
38.6
66
47
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
15.1
38.4
64
43
XCK00
NOMESCO Finland
Perimetry
2.6
38.3
307
1258
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
23.2
38.3
55
24
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.2
37.9
76
76
G91.1
ICD-10 Finland
Obstructive hydrocephalus
21.0
37.8
56
27
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
45.5
36.9
45
10
R4120
NOMESCO Finland
Occupational therapy
2.8
36.8
250
929
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
4.2
35.3
139
340
GBB00
NOMESCO Finland
Tracheostomy
6.0
34.7
98
167
G40.10
ICD-10 Finland
Simple partial seizures
12.3
34.6
63
52
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
34.5
301
1290
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
31.8
33.5
44
14
43098
ICD-8 Finland
Subarachnoid haemorrhage, Alia definita, hypertonia non indicata
+∞
33.4
32
*
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
33.4
32
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
33.1
1355
9950
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
5.3
33.0
103
198
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
32.3
311
1401
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.6
32.2
151
432
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
31.8
31.2
41
13
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
12.0
31.1
57
48
WX872
NOMESCO Finland
Intensive care
2.7
30.5
225
879
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
30.5
222
861
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
7.6
30.0
71
95
AAC40
NOMESCO Finland
Extirpation of intracranial arterio-venous malformation
107.5
29.7
32
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
16.4
29.3
47
29
C08CA01
ATC
amlodipine; oral
1.5
28.7
1366
10290
TAB00
NOMESCO Finland
Lumbar puncture
3.0
28.7
171
584
4301A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]
+∞
28.1
27
*
B01AC07
ATC
dipyridamole; systemic
2.9
28.1
179
639
AAK80
NOMESCO Finland
Partial excision of skull cap
78.2
27.8
31
*
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
42.8
27.7
34
8
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
100.8
27.7
30
*
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
25.5
27.4
38
15
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.1
27.1
54
54
43009
ICD-8 Finland
Subarachnoid haemorrhage, NUD, cum hypertonia
+∞
27.1
26
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
26.9
240
1038
WX730
NOMESCO Finland
Conventional respirator
4.5
26.9
98
224
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.7
26.4
120
335
AAF15
NOMESCO Finland
Ventriculoatrial shunt
16.3
26.2
42
26
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
23.3
26.1
37
16
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.0
25.4
326
1665
A28
ICPC
Limited function/disability NOS
1.7
25.3
604
3814
AAK00
NOMESCO Finland
Cranioplasty
35.8
25.2
32
9
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
6.0
25.2
70
118
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
14.6
25.1
42
29
S06.3
ICD-10 Finland
Focal brain injury
4.6
24.9
88
195
XX4AW
NOMESCO Finland
NA
39.1
24.9
31
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
24.7
239
1076
-
ICD-10 Finland
NA
3.3
24.6
130
409
AA1AA
NOMESCO Finland
Head X-ray examination
6.2
24.6
67
110
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.9
24.4
49
50
WX882
NOMESCO Finland
High dependency care
3.3
24.1
124
383
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
87.3
23.7
26
*
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
26.9
23.5
32
12
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
23.4
915
6539
43091
ICD-8 Finland
Subarachnoid haemorrhage, Postaneyrisma arteriovenosum, hypertonia non indicata
+∞
22.9
22
*
N19
ICPC
Speech disorder
6.5
22.9
60
94
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
65.3
22.8
26
*
M01AH05
ATC
etoricoxib; oral
0.7
22.7
1345
16652
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
18.0
22.1
34
19
G40
ICD-10 Finland
Epilepsy
7.9
21.9
50
64
C09AA02
ATC
enalapril; systemic
1.5
21.8
781
5455
G91.8
ICD-10 Finland
Other hydrocephalus
80.5
21.7
24
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.2
21.6
118
382
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
21.5
314
1686
R42
ICD-10 Finland
Dizziness and giddiness
1.5
21.1
739
5128
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.5
21.1
100
291
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
+∞
20.8
20
*
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
21.6
20.8
30
14
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
77.2
20.7
23
*
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
5.5
20.6
61
112
N28
ICPC
Limited function/disability (N)
4.2
20.6
79
191
2132
FHL
Ventricular operators sunt
110.6
20.6
22
*
SPAT1229
SPAT
Assessment of need for aid
1.9
20.5
316
1728
R4130
NOMESCO Finland
Speech therapy
3.9
20.5
85
221
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
7.9
20.2
46
59
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
7.5
20.1
47
63
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
16.1
20.1
32
20
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
20.1
220
1051
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
20.0
537
3487
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
9.2
19.8
41
45
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
19.7
576
3823
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
200.9
19.6
20
*
W19
ICD-10 Finland
Unspecified fall
1.8
19.4
334
1898
183
Kela drug reimbursment
Lamotrigin and topiramate
7.3
19.2
46
64
C07AB02
ATC
metoprolol; systemic
1.5
18.9
813
5893
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.6
18.9
48
73
G942, I602
ICD-10 Finland
NA
+∞
18.8
18
*
C10AA01
ATC
simvastatin; oral
1.4
18.6
1605
13208
G44.2
ICD-10 Finland
Tension-type headache
1.7
18.5
402
2456
M03BX01
ATC
baclofen; systemic
3.8
18.2
77
205
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
17.8
324
1878
4308X
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS ALIA DEFINITA]
+∞
17.7
17
*
I67.0
ICD-10 Finland
Dissection of cerebral arteries, nonruptured
36.9
17.6
22
6
T90.5
ICD-10 Finland
Sequelae of intracranial injury
4.4
17.5
63
144
N06AB04
ATC
citalopram; systemic
1.5
17.5
705
5026
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
17.4
225
1150
ZXY02
NOMESCO Finland
Neuropsychologist
10.1
17.4
34
34
SPAT1252
SPAT
Overall medication plan or its review
1.9
17.1
267
1470
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.2
17.0
170
781
R51
ICD-10 Finland
Headache
2.3
17.0
153
668
PA6AD
NOMESCO Finland
CT of neck arteries
6.8
16.9
42
62
N05BA09
ATC
clobazam; oral
10.7
16.9
32
30
WW200
SPAT
NA
1.7
16.9
338
2015
I61
ICD-10 Finland
Intracerebral haemorrhage
21.9
16.8
24
11
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
21.9
16.8
24
11
I61.2
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, unspecified
35.2
16.7
21
6
R1260
NOMESCO Finland
Evaluation of communicative skills
3.9
16.3
67
174
C07AB07
ATC
bisoprolol; oral
1.3
16.1
1705
14372
G81.1
ICD-10 Finland
Spastic hemiplegia
47.7
16.0
19
*
S06.0
ICD-10 Finland
Concussion
1.7
15.9
326
1956
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
12.2
15.8
28
23
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
12.2
15.8
28
23
Z2446
NOMESCO Finland
Social worker
2.0
15.6
212
1108
N03AX18
ATC
lacosamide; systemic
7.8
15.5
35
45
PA7KT
NOMESCO Finland
Temporary closure of brain artery
160.6
15.5
16
*
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.7
15.4
318
1913
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
9.2
15.1
31
34
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
17.8
15.1
23
13
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
11.8
15.0
27
23
P20
ICPC
Memory disturbance
1.6
14.9
444
2953
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
15.1
14.8
24
16
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
14.8
231
1268
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
14.7
587
4167
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
4.0
14.5
57
143
SPAT1216
SPAT
Assessment of functional ability
1.5
14.5
547
3835
N88
ICPC
Epilepsy
7.3
14.4
34
47
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
14.4
525
3652
A98
ICPC
Health maint/preventive medicine
0.7
14.3
3046
32474
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
14.2
304
1849
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
4.5
14.2
50
113
I63
ICD-10 Finland
Cerebral infarction
19.2
14.2
21
11
R55
ICD-10 Finland
Syncope and collapse
1.6
14.0
362
2323
B01AA03
ATC
warfarin; systemic
1.4
13.9
724
5409
C09AA05
ATC
ramipril; oral
1.4
13.9
859
6617
H53.2
ICD-10 Finland
Diplopia
2.6
13.8
101
395
R41.0
ICD-10 Finland
Disorientation, unspecified
2.4
13.7
115
486
N06AB10
ATC
escitalopram; oral
1.5
13.6
530
3736
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
12.1
13.6
24
20
NK6AI
NOMESCO Finland
Other cone beam scan
34.1
13.5
17
5
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
13.5
306
1891
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
13.5
231
1314
G40.89
ICD-10 Finland
Other epilepsy
9.4
13.4
27
29
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
13.3
437
2964
N05AH04
ATC
quetiapine; oral
1.5
13.2
450
3080
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.8
12.9
240
1400
YKA02
NOMESCO Finland
Excision of kidneys from cadaver donor
50.1
12.8
15
*
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
4.6
12.7
43
94
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
14.1
12.7
21
15
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
12.7
128
593
I61.3
ICD-10 Finland
Intracerebral haemorrhage in brain stem
15.4
12.6
20
13
74789
ICD-8 Finland
Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system
70.1
12.6
14
*
43008
ICD-8 Finland
Subarachnoid haemorrhage, Alii definiti, cum hypertonia
+∞
12.5
12
*
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
10.1
12.5
24
24
G41.9
ICD-10 Finland
Status epilepticus, unspecified
5.8
12.4
34
59
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
5.8
12.4
34
59
XX3XW
NOMESCO Finland
NA
7.1
12.3
29
41
S02.11
ICD-10 Finland
Fracture of base of skull, open
7.4
12.2
28
38
N02BE01
ATC
paracetamol; systemic, rectal
1.3
12.2
3062
28550
Z3226
NOMESCO Finland
Physiotherapist
1.4
12.1
586
4307
PA2AG
NOMESCO Finland
Restrected MRI examination of vessels in the head with high intensity magnet
12.4
12.1
21
17
R1250
NOMESCO Finland
Evaluation of functional capability
2.8
12.1
79
290
Z3231
NOMESCO Finland
Registered nurse
1.3
12.0
886
7001
G03.9
ICD-10 Finland
Meningitis, unspecified
10.0
12.0
23
23
RP120
NOMESCO Finland
NA
46.8
11.9
14
*
C10AA05
ATC
atorvastatin; oral
1.3
11.8
1261
10506
SPAT1254
SPAT
Administration of medicine
1.5
11.8
488
3484
C03CA01
ATC
furosemide; systemic
1.3
11.6
1081
8834
SPAT1234
SPAT
Support of social functional capacity
1.8
11.5
184
1023
C08CA02
ATC
felodipine; oral
1.6
11.5
334
2205
2102
FHL
Exploratory craniotomy and / or cranectomy
+∞
11.5
11
*
2164
FHL
Crotigree
+∞
11.5
11
*
TKC20
NOMESCO Finland
Catheterisation of bladder
1.7
11.5
244
1484
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
7.9
11.3
25
32
Z50.5
ICD-10 Finland
Speech therapy
4.1
11.3
42
102
C02AC05
ATC
moxonidine; oral
1.9
11.2
158
840
WX892
NOMESCO Finland
Monitored bed care
1.7
11.1
232
1403
S01.0
ICD-10 Finland
Open wound of scalp
1.7
11.1
250
1542
SPAT1251
SPAT
Organisation of medication
2.0
10.9
131
655
RS221
NOMESCO Finland
NA
3.2
10.9
55
172
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
3.1
10.9
57
183
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
10.8
440
3127
RS313
NOMESCO Finland
NA
8.3
10.8
23
28
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
8.3
10.8
23
28
A06AD11
ATC
lactulose; oral
1.4
10.6
523
3854
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.0
10.6
128
641
WX320
NOMESCO Finland
Spinalanesthesy
0.7
10.5
438
5875
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.4
10.5
88
375
43599
ICD-8 Finland
Transient cerebral ischaemia, Without mention of hypertension
+∞
10.4
10
*
4351A
ICD-9 Finland
Transient cerebral ischaemia, Vertebral artery syndrome
+∞
10.4
10
*
G942, I601
ICD-10 Finland
NA
+∞
10.4
10
*
43399
ICD-8 Finland
Cerebral thrombosis, Without mention of hypertension
+∞
10.4
10
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
10.6
10.3
19
18
G44.8
ICD-10 Finland
Other specified headache syndromes
3.9
10.2
41
107
PA2HT
NOMESCO Finland
Extensive embolisation of arterio-venous malformation of the brain
23.4
10.2
14
6
N05BA01
ATC
diazepam; systemic, rectal
1.4
10.2
426
3042
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
10.2
827
6608
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
7.5
10.2
23
31
OAB43
SPAT
NA
0.6
10.1
126
2162
RS340
NOMESCO Finland
NA
11.3
10.0
18
16
R01AD12
ATC
fluticasone furoate; nasal
0.7
10.0
475
6248
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.1
9.9
105
499
A41.9
ICD-10 Finland
Sepsis, unspecified
2.0
9.9
130
675
GBB03
NOMESCO Finland
Percutaneous tracheostomy
16.7
9.9
15
9
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.4
9.8
34
78
C08CA13
ATC
lercanidipine; oral
1.4
9.8
435
3143
N03AX09
ATC
lamotrigine; oral
2.1
9.8
106
508
C09CA06
ATC
candesartan; oral
1.3
9.7
659
5127
AAK85
NOMESCO Finland
Replantation of previously excised part of skull cap
55.1
9.6
11
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
9.6
534
4013
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
9.6
433
3137
C09BA02
ATC
enalapril and diuretics; systemic
1.5
9.6
302
2030
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
11.4
9.5
17
15
ZXD00
NOMESCO Finland
Emergency procedure
2.1
9.5
109
537
N30.0
ICD-10 Finland
Acute cystitis
1.4
9.5
408
2930
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.8
9.4
850
10272
AA9PW
NOMESCO Finland
NA
100.2
9.4
10
*
AXX01
SPAT
NA
3.0
9.4
51
170
2127
FHL
Ventriculostomy
+∞
9.4
9
*
YFA50
NOMESCO Finland
Excision of heart for preparation of homograft
+∞
9.4
9
*
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
21.7
9.3
13
6
WX704
NOMESCO Finland
Intubation
1.7
9.3
208
1284
ZX122
NOMESCO Finland
Intra-arterial
6.9
9.3
22
32
L28
ICPC
Limited function/disability (L)
1.4
9.3
525
3960
W10
ICD-10 Finland
Fall on and from stairs and steps
1.8
9.3
150
838
N05AX08
ATC
risperidone; systemic
1.6
9.2
250
1625
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.4
9.2
74
312
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.0
9.1
50
168
XA400
NOMESCO Finland
EEG
5.3
9.0
26
49
R53
ICD-10 Finland
Malaise and fatigue
1.3
9.0
613
4761
315
Kela drug reimbursment
Clopidogrel
4.2
9.0
32
76
K89
ICPC
Transient cerebral ischaemia
6.5
8.9
22
34
4319X
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS NUD]
18.6
8.9
13
7
I62.1
ICD-10 Finland
Nontraumatic extradural haemorrhage
18.6
8.9
13
7
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
12.5
8.9
15
12
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.0
8.8
33
82
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
6.3
8.8
22
35
N06AX11
ATC
mirtazapine; oral
1.3
8.8
952
7888
R47.1
ICD-10 Finland
Dysarthria and anarthria
4.1
8.7
32
78
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
50.1
8.7
10
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.2
8.6
86
399
N05BA04
ATC
oxazepam; oral
1.3
8.6
759
6115
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
6.9
8.5
20
29
Z43.0
ICD-10 Finland
Attention to tracheostomy
10.0
8.5
16
16
G93.90
ICD-10 Finland
Brain death
27.6
8.5
11
*
PA2JT
NOMESCO Finland
Very extensive embolisation of arterio-venous malformation of the brain
90.2
8.4
9
*
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
12.8
8.4
14
11
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.4
8.4
65
269
RF420
NOMESCO Finland
NA
3.0
8.3
46
156
4360A
ICD-9 Finland
Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]
+∞
8.3
8
*
4359X
ICD-9 Finland
Transient cerebral ischaemia, Unspecified transient cerebral ischaemia
+∞
8.3
8
*
4350A
ICD-9 Finland
Transient cerebral ischaemia, Basilar artery syndrome
+∞
8.3
8
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.5
8.3
37
107
79199
ICD-8 Finland
Headache
2.7
8.3
54
202
H35.6
ICD-10 Finland
Retinal haemorrhage
4.3
8.3
29
68
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
2.7
8.3
53
196
JDB10
NOMESCO Finland
Percutaneous gastrostomy
2.9
8.3
48
167
C09CA01
ATC
losartan; oral
1.3
8.3
777
6316
ZXA00
NOMESCO Finland
Right side
1.3
8.3
901
7463
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
8.2
938
7816
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.5
8.1
60
241
Z00.0
ICD-10 Finland
General medical examination
1.3
8.1
539
4166
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
6.0
8.1
21
35
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
6.0
8.1
21
35
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
8.1
334
2377
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
33.4
8.1
10
*
4311A
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]
17.2
8.1
12
7
C03AA03
ATC
hydrochlorothiazide; oral
1.5
8.1
314
2212
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.7
8.1
52
194
S06.2
ICD-10 Finland
Diffuse brain injury
3.2
8.0
39
121
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
8.0
240
1597
J01EA01
ATC
trimethoprim; systemic
1.3
8.0
799
6541
C08CA05
ATC
nifedipine; systemic
1.6
7.9
210
1358
Z02.4
ICD-10 Finland
Examination for driving licence
0.8
7.9
502
6355
N29
ICPC
Neurological sympt/complt other
2.5
7.9
61
250
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
5.1
7.8
23
45
ZYC01
SPAT
NA
1.7
7.8
148
874
S02.00
ICD-10 Finland
Fracture of the upper part of the head closed
4.8
7.7
24
50
RF120
NOMESCO Finland
NA
3.0
7.7
41
136
PA2GT
NOMESCO Finland
Embolisation of arterio-venous malformation of the brain
45.0
7.7
9
*
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.1
7.7
80
382
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
5.3
7.7
22
42
S22.4
ICD-10 Finland
Multiple fractures of ribs
2.5
7.7
58
238
S06.4
ICD-10 Finland
Epidural haemorrhage
6.7
7.6
18
27
I67.2
ICD-10 Finland
Cerebral atherosclerosis
5.7
7.5
20
35
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
7.1
7.5
17
24
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
7.5
76
360
N80
ICPC
Head injury other
2.6
7.4
50
193
44209
ICD-8 Finland
Other aneurysm, Ruptura non indicata
80.2
7.4
8
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.7
7.4
146
874
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
7.6
7.4
16
21
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.0
7.4
27
67
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.5
7.3
229
1540
W06
ICD-10 Finland
Fall involving bed
3.3
7.3
34
103
PCU93
NOMESCO Finland
Injection of therapeutic or sclerosing agent into bypass from suprarenal abdominal aorta and visceral arteries
+∞
7.3
7
*
G942, I690
ICD-10 Finland
NA
+∞
7.3
7
*
XA800
SPAT
NA
+∞
7.3
7
*
G942, I609
ICD-10 Finland
NA
+∞
7.3
7
*
4331A
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]
+∞
7.3
7
*
G942, I600
ICD-10 Finland
NA
+∞
7.3
7
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.0
7.2
88
448
PA2BM
NOMESCO Finland
MRI examination of vessels in the head with 3 Tesla magnet
15.8
7.2
11
7
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
7.2
617
4946
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
7.2
305
2186
C02EA02
ATC
NA
1.6
7.2
159
984
N03AE01
ATC
clonazepam; systemic
1.6
7.1
171
1081
N02AA05
ATC
oxycodone; systemic
1.3
7.0
476
3691
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.1
7.0
72
343
N06AA09
ATC
amitriptyline; systemic
1.4
6.9
299
2151
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
0.5
6.9
70
1266
SPAT1101
SPAT
Orthostatic test
1.7
6.9
148
908
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.9
6.9
93
491
S06.9
ICD-10 Finland
Intracranial injury, unspecified
3.8
6.8
27
72
G41.0
ICD-10 Finland
Grand mal status epilepticus
8.3
6.8
14
17
R01AD08
ATC
fluticasone; nasal
0.8
6.8
542
6679
B01AF01
ATC
rivaroxaban; oral
0.7
6.8
201
2862
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
6.1
6.8
17
28
WW806
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by doctor
40.1
6.8
8
*
RT152
NOMESCO Finland
NA
40.1
6.8
8
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
6.7
287
2062
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.7
6.6
120
702
OAB48
SPAT
NA
0.5
6.6
53
1025
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
6.6
145
895
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.1
6.6
34
112
I72.0
ICD-10 Finland
Aneurysm and dissection of carotid artery
8.7
6.5
13
15
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
8.7
6.5
13
15
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
4.8
6.5
20
42
R60.0
ICD-10 Finland
Localized oedema
1.4
6.5
325
2400
H47.2
ICD-10 Finland
Optic atrophy
5.3
6.4
18
34
WYA20
NOMESCO Finland
Home visit
2.3
6.4
53
229
AAC20
NOMESCO Finland
Anastomosis to intracranial vessel
69.9
6.4
7
*
AAC10
NOMESCO Finland
Reinforcement of intracranial aneurysm wall
69.9
6.4
7
*
N99
ICPC
Neurological disease other
2.9
6.4
37
130
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
6.4
903
7676
R11
ICD-10 Finland
Nausea and vomiting
1.5
6.3
207
1409
N01
ICPC
Headache
1.5
6.3
204
1385
I65.0
ICD-10 Finland
Occlusion and stenosis of vertebral artery
8.1
6.3
13
16
3792A
ICD-9 Finland
Other disorders of eye, Disorders of vitreous body
11.0
6.3
11
10
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.1
6.3
32
105
SPAT1053
SPAT
Memory test
1.3
6.3
504
4001
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.7
6.3
150
2218
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
18.0
6.3
9
5
G942, I606
ICD-10 Finland
NA
+∞
6.2
6
*
C02DE03
ATC
NA
+∞
6.2
6
*
RP140
NOMESCO Finland
NA
+∞
6.2
6
*
YJA10
NOMESCO Finland
Excision of liver from cadaver donor
+∞
6.2
6
*
Y3090
ICD-8 Finland
NA
+∞
6.2
6
*
4349A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]
+∞
6.2
6
*
2163
FHL
Proxies. Vascular ligation, big brain
+∞
6.2
6
*
AAK99
NOMESCO Finland
Other operation on skull or dura
26.7
6.2
8
*
N03AX23
ATC
brivaracetam; systemic
26.7
6.2
8
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
4.8
6.2
19
40
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
7.0
6.2
14
20
A12BA01
ATC
potassium chloride; oral
1.6
6.2
160
1031
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
6.2
157
1010
J96.0
ICD-10 Finland
Acute respiratory failure
2.5
6.2
45
183
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.7
6.2
114
673
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
3.9
6.2
23
59
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.5
6.2
181
1202
3AX01
NOMESCO Finland
NA
4.5
6.1
20
45
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
2.4
6.1
47
194
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
5.3
6.1
17
32
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
6.1
145
917
S22.3
ICD-10 Finland
Fracture of rib
1.5
6.1
185
1240
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.2
6.1
59
276
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.6
6.1
41
160
GBB96
NOMESCO Finland
Other tracheostomy procedure
12.5
6.1
10
8
D21
ICPC
Swallowing problem
2.6
6.0
41
161
RS230
NOMESCO Finland
NA
4.9
6.0
18
37
I50.0
ICD-10 Finland
Congestive heart failure
1.4
6.0
244
1735
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
254
241
11.14
234.80
3.9
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
327
602
5.80
170.56
3.0
1.3
e6/l
78.2
26.4
3.29
280
463
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
327
603
5.79
170.26
3.0
1.4
e6/l
17532.4
708.3
4.54
283
488
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
184
194
9.86
157.37
2.2
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
289
553
5.53
144.24
3.2
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
317
698
4.82
134.50
2.1
1.3
mg/l
868.3
537.0
1.60
302
656
(3018677) aPTT in Platelet poor plasma by Coagulation assay
987
4525
2.53
128.66
2.1
2.0
s
28.9
30.0
5.99
959
4372
(3003396) Base excess in Arterial blood by calculation
895
4054
2.53
118.70
10.2
6.8
mmol/l
1.4
1.2
1.00
706
3117
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
895
4071
2.51
117.53
10.2
6.8
kpa
5.0
5.1
1.46
863
3857
(3027801) Oxygen [Partial pressure] in Arterial blood
894
4069
2.51
117.22
10.2
6.8
kpa
13.1
12.1
4.33
862
3853
(3016018) Differential panel - Cerebral spinal fluid
182
282
6.70
112.45
3.9
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
123
123
10.27
109.10
5.0
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1627
9751
2.08
108.16
2.5
2.0
u/l
270.3
232.2
0.27
1549
8994
(3014576) Chloride [Moles/volume] in Serum or Plasma
878
4434
2.23
88.19
7.9
6.5
mmol/l
104.7
104.3
1.34
859
4323
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
245
612
4.19
88.06
1.8
1.2
mmol/l
3.7
3.8
0.28
225
570
(3043409) Potassium [Moles/volume] in Arterial blood
338
1081
3.31
84.38
8.7
3.9
mmol/l
3.8
3.9
1.75
327
1008
(3002173) Hemoglobin [Mass/volume] in Arterial blood
709
3338
2.35
83.77
11.7
7.6
g/l
121.8
120.9
0.57
689
3204
(3016502) Oxygen saturation in Arterial blood
750
3634
2.29
82.76
11.2
7.2
%
95.8
95.5
0.58
724
3492
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
68
43
16.05
79.57
2.0
1.2
%
33.1
62.6
2.49
57
17
(3023410) Appearance of Cerebral spinal fluid
146
258
5.82
78.98
4.0
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
533
2263
2.55
78.75
14.0
6.6
mmol/l
24.9
24.6
0.79
508
2097
(3019060) Gas panel - Arterial blood
548
2405
2.47
75.27
9.5
4.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
662
3163
2.29
74.96
6.1
6.6
mmol/l
7.7
10.7
22.15
618
2999
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
127
206
6.32
74.94
2.5
1.3
mmol/l
2.9
2.1
4.22
113
193
(3020891) Body temperature
378
1444
2.77
68.67
8.8
4.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
87
102
8.69
68.41
3.7
2.5
umol/l
30.7
28.9
0.52
72
72
(3003458) Phosphate [Moles/volume] in Serum or Plasma
818
4500
2.01
63.46
5.7
5.6
mmol/l
1.0
1.0
5.90
758
4144
(3012095) Magnesium [Moles/volume] in Serum or Plasma
932
5586
1.85
55.03
3.1
3.2
mmol/l
0.8
0.8
6.07
857
5160
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
85
134
6.45
51.57
2.2
1.4
%
44.1
67.9
1.81
36
16
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
70
90
7.89
51.04
1.6
1.3
%
19.3
17.3
0.07
44
11
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
594
3152
2.03
50.02
2.7
2.3
ug/l
4.7
6.9
4.82
524
2685
(40761535) Cells panel - Urine sediment
561
2946
2.04
48.54
3.8
3.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1087
7211
1.68
43.63
4.9
4.2
kg/l
1.0
1.0
0.12
110
1105
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
68
103
6.69
42.87
2.2
2.3
umol/l
55.7
51.6
0.40
54
74
(3009542) Hematocrit [Volume Fraction] of Blood
2538
29771
0.64
42.36
21.6
16.3
%
38.5
39.3
3.76
1607
19975
(3003181) Sodium [Moles/volume] in Urine
183
625
3.01
40.57
1.7
1.3
mmol/l
90.9
62.9
8.22
148
501
(3036489) Thrombin time
230
927
2.57
37.19
2.1
2.0
s
20.2
21.8
6.43
213
805
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
371
1838
2.11
37.14
10.0
8.9
mmol/l
24.2
24.4
0.77
355
1695
(3023368) Bacteria identified in Blood by Culture
1366
10017
1.53
34.46
4.4
4.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1114
7863
1.56
33.16
4.4
3.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2431
20144
1.48
33.12
8.0
4.5
mmol/l
7.0
6.8
3.14
2306
18872
(3009466) Valproate [Moles/volume] in Serum or Plasma
122
380
3.28
31.62
3.8
5.1
umol/l
365.4
350.3
0.49
99
338
(3022217) INR in Platelet poor plasma by Coagulation assay
734
4857
1.62
28.19
23.4
26.0
inr
1.3
1.4
0.82
65
677
(1761868) Lipid panel - Serum or Plasma
753
10833
0.63
28.18
3.1
3.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1147
8390
1.50
28.12
4.7
3.8
%
89.0
88.5
0.29
1118
8170
(3029937) Albumin [Presence] in Urine by Test strip
1206
8935
1.49
27.69
5.0
4.2
estimate
0.0
0.0
1.28
280
2947
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1702
13474
1.44
27.59
4.4
3.7
ng/l
43.3
111.2
1.21
1327
9653
(3026008) Bacteria identified in Urine by Culture
1411
10847
1.45
26.53
3.7
3.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
480
2891
1.74
26.27
9.5
7.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
681
4508
1.61
25.93
9.6
7.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
501
3067
1.72
25.84
8.1
6.4
mmol/l
1.4
1.4
0.26
486
2945
(40768804) Tissue Pathology biopsy report
1054
13899
0.68
25.05
2.1
2.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
363
2041
1.85
24.99
9.8
7.1
mmol/l
24.2
25.0
4.51
353
2025
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2938
32454
0.70
24.33
4.4
4.4
mmol/l
1.4
1.5
6.78
2704
29339
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2850
31642
0.70
24.23
17.2
14.4
ml/min/173m2
78.6
76.6
4.98
2437
26036
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2975
32737
0.70
23.44
4.5
4.5
mmol/l
4.5
4.7
17.86
2766
29787
(4034850)
219
1063
2.12
23.00
12.7
10.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
78
230
3.44
22.13
1.3
1.4
promille
1.3
1.2
0.34
56
178
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3078
33573
0.70
21.82
5.1
5.0
mmol/l
2.6
2.7
21.48
2849
30403
(3032080) INR in Blood by Coagulation assay
1739
14344
1.36
20.01
9.4
9.5
inr
1.2
1.3
3.26
468
3944
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
115
451
2.59
19.74
4.3
6.5
mg/l
10.8
12.1
2.54
108
415
(3023183) Ammonium ion [Moles/volume] in Plasma
149
659
2.31
19.70
2.3
2.8
umol/l
32.9
36.1
0.58
129
546
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
41
83
4.98
19.21
1.5
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3327
35620
0.70
18.73
11.3
10.6
u/l
25.8
25.9
0.06
3224
34083
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
285
1632
1.80
18.41
3.5
3.9
%
52.1
47.9
1.86
280
1609
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
223
1181
1.94
18.41
2.9
2.6
u/ml
0.3
0.3
0.74
131
661
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
172
833
2.11
18.20
2.6
2.4
g/l
3.8
3.6
0.78
162
794
(3002385) Erythrocyte distribution width [Ratio]
2415
27096
0.75
18.08
23.4
18.4
%
13.9
13.8
4.17
2365
26417
(3010813) Leukocytes [#/volume] in Blood
3474
36870
0.69
17.94
28.5
22.2
e9/l
7.2
6.8
17.72
3396
35597
(3000963) Hemoglobin [Mass/volume] in Blood
3474
36869
0.69
17.92
28.7
22.3
g/l
131.7
134.3
20.21
3425
36183
(3026361) Erythrocytes [#/volume] in Blood
3474
36862
0.70
17.80
28.5
22.2
e12/l
4.4
4.5
24.04
3395
35605
(3024731) MCV [Entitic volume]
3474
36858
0.70
17.72
28.4
22.1
fl
91.8
91.4
4.79
3426
36162
(3035941) MCH [Entitic mass]
3474
36858
0.70
17.72
28.4
22.1
pg
30.5
30.4
2.24
3426
36162
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3018
32748
0.73
17.59
4.7
4.8
mmol/l
6.1
6.0
1.26
2755
29357
(3007461) Platelets [#/volume] in Blood
3474
36848
0.70
17.54
28.5
22.2
e9/l
251.4
246.6
3.65
3399
35724
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1899
16103
1.32
17.24
9.1
5.8
mmol/l
1.2
1.2
33.72
1760
14453
(3044640) Blood type and Crossmatch panel - Blood
1349
10922
1.34
16.74
2.6
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
335
2070
1.67
16.48
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
218
1204
1.85
15.85
2.2
2.2
ug/l
434.5
719.1
0.81
207
1137
(3024354) Oxygen [Partial pressure] in Venous blood
415
2729
1.58
15.85
3.1
3.0
kpa
4.6
4.5
0.57
397
2634
(3051593) INR in Capillary blood by Coagulation assay
42
102
4.15
15.79
4.4
26.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1051
8296
1.35
15.14
2.5
2.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
482
3319
1.51
14.90
3.9
3.5
kpa
5.9
5.8
0.07
466
3210
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2889
31326
0.76
14.70
4.2
4.0
mmol/l
1.4
1.3
4.01
2652
28055
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
256
1518
1.73
14.67
2.6
1.9
ug/l
1.9
2.3
0.23
210
1332
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2879
31211
0.76
14.45
6.1
6.0
mmol/mol
40.6
40.3
1.13
2680
28447
(3015736) pH of Urine
1533
12841
1.30
14.40
4.3
3.5
—
5.7
—
0
9
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
779
5905
1.39
14.37
1.9
1.8
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
154
784
2.00
14.30
13.5
7.0
mmol/l
105.9
105.2
0.66
135
694
(3039000) Anion gap in Blood
154
784
2.00
14.30
13.5
7.0
mmol/l
11.0
11.3
0.35
135
694
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
267
1618
1.69
14.13
2.9
2.5
%
0.7
0.7
1.10
261
1543
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
300
1881
1.64
13.93
12.1
9.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
65
230
2.85
13.71
1.2
1.2
mmol/l
28.6
35.3
1.86
53
191
(3002032) Base excess in Venous blood by calculation
474
3308
1.49
13.69
4.0
3.6
mmol/l
2.1
2.0
0.26
393
2673
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
563
4070
1.44
13.54
1.8
1.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
246
1487
1.69
13.15
9.5
5.1
%
1.7
1.6
1.20
225
1387
(3007930) Methemoglobin/Hemoglobin.total in Blood
242
1468
1.69
12.78
9.6
5.2
%
1.0
0.9
1.63
222
1370
(3027273) Bicarbonate [Moles/volume] in Venous blood
279
1759
1.63
12.68
3.3
3.3
mmol/l
25.3
25.3
0.13
272
1699
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
558
4081
1.42
12.55
1.7
1.7
—
—
—
0
0
(3013512) EKG study
843
10582
0.75
12.53
4.3
4.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
329
2171
1.56
12.34
3.2
3.0
g/l
126.4
128.1
0.68
322
2114
(3047181) Lactate [Moles/volume] in Blood
191
1096
1.78
12.30
12.6
6.1
mmol/l
1.3
1.3
0.08
164
960
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2024
17795
1.26
12.21
9.5
6.6
mmol/l
1.2
1.2
22.55
1792
14903
(3008295) Osmolality of Serum or Plasma
81
342
2.39
12.04
2.0
1.3
mosm/kgh2o
284.0
276.8
1.67
61
257
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
697
8923
0.74
11.71
1.6
1.6
mmol/l
1.5
1.4
1.19
597
7372
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
533
7105
0.71
11.58
2.9
3.1
ug/l
0.8
0.8
0.29
373
4868
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
150
815
1.87
11.56
2.3
2.1
%
95.3
90.1
2.07
143
764
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
297
4403
0.65
11.41
4.6
4.5
%
34.0
32.5
1.41
211
2783
(3007853) Bacteria identified in Skin by Aerobe culture
532
3921
1.41
11.40
1.9
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
123
2284
0.52
11.40
2.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1478
12650
1.26
10.84
4.9
4.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
119
2193
0.53
10.76
1.4
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
1470
12603
1.25
10.55
3.9
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
182
1080
1.72
10.47
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2829
30369
0.80
10.45
4.7
4.7
mu/l
2.0
2.1
0.68
2601
27278
(3042936) Bacteria identified in Isolate by Culture
640
4940
1.35
10.26
2.0
2.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
52
196
2.67
9.84
2.3
2.3
umol/l
23.4
27.6
—
5
18
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
43
149
2.90
9.53
1.1
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1752
15439
1.23
9.47
5.2
4.7
g/l
33.9
35.1
13.47
1627
14217
(3002256) Pathology report gross observation
335
4669
0.69
9.28
1.3
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
13
18
7.24
8.84
1.5
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
40
142
2.83
8.52
1.1
1.1
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
16
29
5.53
8.49
2.1
1.1
%
18.4
23.8
—
8
9
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1041
12243
0.80
8.49
4.7
5.1
ug/l
7.5
3.6
0.35
938
10911
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1776
15797
1.21
8.42
4.4
4.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
87
445
1.97
8.14
1.8
2.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1625
18127
0.83
7.49
2.6
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1832
16466
1.20
7.48
4.6
3.8
estimate
0.0
0.0
0.50
300
3039
(3001019) Free T4 and TSH panel - Serum or Plasma
64
1244
0.51
6.95
1.8
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1845
16705
1.18
6.66
4.6
3.8
estimate
0.0
0.0
1.34
294
2992
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
85
1496
0.56
6.66
1.5
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1434
16054
0.84
6.59
6.0
6.0
%
25.6
27.1
6.11
1332
14781
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
369
2803
1.35
6.52
2.9
2.7
ml/min/173m2
62.5
62.8
0.04
161
1148
(40761511) CBC panel - Blood by Automated count
3309
34492
0.82
6.49
19.0
14.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2321
24942
0.85
6.46
4.0
4.1
mm/h
15.2
13.4
5.05
2159
22755
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
340
2558
1.36
6.40
2.0
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
847
7164
1.23
6.34
1.8
1.8
nmol/l
1302.9
1163.1
4.13
692
5287
(3022096) Basophils/100 leukocytes in Blood
1358
15183
0.85
5.97
6.0
5.9
%
0.7
0.7
0.56
1270
14034
(42870588) Differential panel, method unspecified - Blood
1009
11569
0.83
5.92
5.5
5.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1812
16506
1.17
5.81
5.7
5.1
estimate
0.0
0.0
0.50
290
3066
(3040151) Glucose [Moles/volume] in Capillary blood
78
433
1.82
5.81
4.9
5.6
mmol/l
7.4
7.3
0.14
57
355
(3031040) Bacteria [#/volume] in Urine by Automated count
2423
22592
1.17
5.72
5.4
4.6
e6/l
1753.0
2631.0
0.31
31
355
(3018010) Neutrophils/100 leukocytes in Blood
1422
15796
0.85
5.70
5.8
5.8
%
58.9
57.8
2.33
1329
14616
(4035726)
233
3174
0.72
5.62
1.3
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1410
15618
0.86
5.35
5.9
5.9
%
2.9
2.9
0.26
1313
14419
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
802
6862
1.21
5.27
4.2
3.8
ng/l
440.4
560.4
0.28
664
5638
(4198724)
21
69
3.05
5.21
1.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
150
1014
1.50
5.19
3.9
3.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1421
15690
0.86
5.10
6.1
6.2
%
8.9
8.8
0.46
1333
14539
(3041096) Erythrocytes [Presence] in Urine by Automated
753
8766
0.83
5.10
4.4
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
378
4738
0.78
5.09
1.3
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1232
10976
1.17
5.06
2.6
2.5
u/l
59.6
58.5
0.17
1152
10080
(3045716) Anion gap in Serum or Plasma
37
165
2.25
5.06
1.9
2.5
mmol/l
8.9
9.3
0.23
29
124
(3022145) Colonoscopy Study observation
291
3772
0.75
5.06
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2364
25137
0.87
4.99
4.0
3.9
pmol/l
15.0
14.9
0.50
2168
22517
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1267
14083
0.86
4.92
2.3
2.2
nmol/l
77.0
79.0
1.62
1139
12414
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1928
20752
0.87
4.72
3.4
3.1
u/l
59.9
53.5
1.85
1794
18917
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
30
126
2.39
4.71
1.7
2.5
umol/l
85.8
165.5
1.04
18
75
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
332
4159
0.78
4.45
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
48
867
0.55
4.25
1.4
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
867
9819
0.85
4.16
4.2
4.4
%
22.0
21.9
0.02
438
4963
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
130
896
1.46
4.16
1.5
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
20
75
2.67
3.98
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
339
4173
0.80
3.93
1.4
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
82
2.57
3.88
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
105
1535
0.68
3.86
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
56
322
1.75
3.83
3.2
2.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
323
3974
0.80
3.73
3.2
4.0
ug/l
24.7
25.3
0.02
276
3234
(3015235) Bicarbonate [Moles/volume] in Capillary blood
132
934
1.43
3.71
3.5
3.2
mmol/l
24.4
25.2
1.26
110
810
(3026782) Osmolality of Urine
798
7028
1.17
3.67
3.4
2.7
mosm/kgh2o
532.7
546.9
1.05
701
5932
(3023103) Potassium [Moles/volume] in Serum or Plasma
3421
35190
0.86
3.66
24.3
17.6
mmol/l
4.0
4.0
2.01
3349
34136
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1954
18282
1.13
3.64
5.6
6.1
umol/l
10.6
11.7
4.75
1851
17325
(40768793) Breast Pathology biopsy report
45
785
0.57
3.58
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
301
3712
0.80
3.56
5.5
4.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
215
1663
1.31
3.47
4.6
3.7
mmol/l
24.2
24.2
0.01
188
1483
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
75
1140
0.65
3.39
1.5
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
1159
10538
1.14
3.38
4.6
4.0
ph
7.4
7.4
1.19
181
2000
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
20
82
2.45
3.38
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
13
42
3.10
3.36
1.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
116
818
1.43
3.36
3.6
3.0
kpa
8.1
7.9
0.73
101
761
(40768800) Prostate Pathology biopsy report
48
803
0.59
3.29
1.3
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
77
2.47
3.29
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
59
361
1.64
3.27
1.6
1.9
u/l
5597.0
1394.2
0.59
22
136
(3019550) Sodium [Moles/volume] in Serum or Plasma
3417
35091
0.87
3.26
24.9
17.5
mmol/l
139.4
139.7
6.25
3353
34098
(3036481) Cortisol [Moles/volume] in Serum or Plasma
349
2889
1.23
3.22
1.9
2.2
nmol/l
368.7
375.1
0.25
315
2632
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
39
213
1.84
3.21
1.5
1.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
78
2.44
3.21
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
435
5108
0.83
3.18
1.3
1.2
u/ml
14.1
12.7
0.15
177
1884
(3000330) Specific gravity of Urine by Test strip
141
1889
0.74
3.17
3.7
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
100
695
1.45
3.15
3.1
2.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
232
2905
0.79
3.15
5.7
4.1
—
—
—
0
0
(3000492) Spirometry study
240
2988
0.79
3.11
1.4
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
57
351
1.63
3.10
1.6
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
39
3.08
3.08
3.5
4.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
148
1950
0.75
2.99
2.4
2.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
35
3.15
2.93
1.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
30
3.34
2.90
1.0
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
77
2.34
2.81
1.1
1.1
%
96.1
88.1
—
7
40
(3021589) Normoblasts [#/volume] in Blood
1374
14761
0.90
2.74
10.2
9.8
e9/l
0.0
0.0
0.18
1156
11969
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
78
2.31
2.74
1.1
1.3
%
99.0
85.9
—
8
42
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
135
1017
1.34
2.70
1.8
1.7
—
—
—
0
0
(4094501)
63
941
0.66
2.69
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
362
3068
1.20
2.66
2.4
2.6
g/l
65.5
66.2
0.98
315
2750
(3000850) Epithelial cells [#/volume] in Urine
828
7475
1.13
2.65
3.3
2.5
e6/l
5.1
5.3
0.18
755
6519
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
275
2274
1.22
2.61
4.4
3.6
kpa
5.2
5.2
0.27
245
2087
(3039443) Prostate specific Ag panel - Serum or Plasma
38
629
0.60
2.57
1.3
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
262
2164
1.22
2.52
4.1
3.6
mmol/l
1.8
2.0
0.35
186
1600
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
96
694
1.39
2.51
1.5
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
270
2240
1.22
2.49
4.3
3.6
ph
7.4
7.4
1.61
44
278
(1617658) Protocol used for examination of sentinel lymph nodes
12
284
0.42
2.46
1.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
666
5962
1.14
2.43
2.9
2.8
e6/l
1.2
1.1
0.35
423
3402
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
38
226
1.69
2.43
1.2
1.2
titre
110.0
121.6
—
9
44
(3028271) Lactate [Moles/volume] in Capillary blood
85
606
1.41
2.41
2.1
1.9
mmol/l
1.8
1.7
0.79
69
589
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
31
174
1.79
2.41
2.6
2.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
207
0.39
2.40
1.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1266
13571
0.90
2.35
3.0
2.8
ug/l
145.9
146.1
0.01
1162
12360
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
114
858
1.34
2.34
1.8
1.6
g/l
0.2
0.2
0.20
106
816
(1761482) Bacteria [#/volume] in Urine by Culture
71
1006
0.70
2.34
5.4
4.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
144
1835
0.78
2.33
1.2
1.2
iu/ml
87.6
141.3
1.20
55
657
(3030467) Casts [#/volume] in Urine by Automated count
1057
9751
1.11
2.31
3.7
3.1
e6/l
0.5
0.4
0.16
859
7365
(36304419) Bacteria [Presence] in Urine
1025
9443
1.11
2.30
3.7
3.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
23
119
1.94
2.30
1.4
2.1
%
147.2
166.1
0.72
23
110
(3017569) Oxygen content in Arterial blood
31
178
1.75
2.26
1.6
2.5
—
—
—
0
0
(3010421) pH of Blood
126
969
1.31
2.24
4.9
4.5
ph
7.4
7.4
0.30
89
814
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
29
3.11
2.22
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
36
2.78
2.20
1.4
2.0
umol/l
19.5
19.2
—
10
36
(1002224) Polysomnography panel
82
1120
0.73
2.19
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
70
979
0.71
2.16
1.7
1.6
mg/l
4.4
4.0
0.07
46
701
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
476
5376
0.87
2.16
1.3
1.3
iu/ml
44.8
35.4
0.43
141
1686
(3017732) Neutrophils [#/volume] in Blood
190
2320
0.81
2.15
3.3
3.3
e9/l
4.0
4.1
0.31
141
1731
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
140
1100
1.28
2.13
1.8
1.6
titre
117.1
275.4
—
7
56
(3008898) HLA-B27 [Presence]
61
871
0.70
2.12
1.0
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2587
26756
0.92
2.09
7.5
7.5
u/l
80.3
80.0
0.07
2436
25054
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
75
539
1.40
2.08
1.7
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3267
33424
0.90
2.07
20.6
15.1
mg/l
26.3
25.5
0.60
2831
26704
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
5
10
5.00
2.07
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
121
938
1.30
2.05
1.2
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
172
1393
1.24
2.05
1.4
1.6
u/ml
4.5
22.4
—
6
36
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
128
1623
0.78
2.03
3.0
3.9
u/ml
30.6
69.4
4.46
123
1567
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
55
376
1.47
2.00
1.5
1.2
u/ml
4.5
2.3
0.44
23
125
(3021440) Promyelocytes/100 leukocytes in Blood
235
2788
0.83
2.00
3.9
4.1
%
0.2
0.1
0.25
62
784
(4146454)
24
415
0.58
1.99
1.6
2.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
40
611
0.65
1.99
3.1
3.6
%
2.4
1.5
0.73
35
456
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
61
858
0.71
1.97
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
121
945
1.29
1.96
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
249
2932
0.84
1.95
3.9
4.1
%
1.0
1.0
0.00
67
842
(3051651) Icteric interference index of Serum or Plasma
29
172
1.69
1.92
3.2
3.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
114
887
1.29
1.91
1.9
1.5
g/l
1.2
1.2
0.40
106
844
(3044242) Glucose [Moles/volume] in Arterial blood
31
188
1.65
1.90
1.4
2.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
208
1737
1.21
1.87
1.7
1.7
g/l
1.5
1.6
0.15
181
1479
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
159
1942
0.81
1.84
1.3
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
38
246
1.55
1.81
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
39
584
0.66
1.79
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
336
2936
1.16
1.78
1.7
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
167
0.42
1.78
1.3
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
208
1.59
1.76
1.4
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
228
2678
0.84
1.76
3.9
3.9
%
0.9
0.6
0.59
45
603
(3017446) Testosterone [Moles/volume] in Serum or Plasma
194
2311
0.83
1.75
2.1
2.2
nmol/l
11.1
12.7
1.90
158
2015
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
10
41
2.44
1.75
1.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
789
7277
1.10
1.72
1.8
1.6
mg/l
1.6
1.3
0.98
634
5615
(3038177) Helicobacter pylori Ab [Presence] in Serum
29
458
0.63
1.72
1.0
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
14
68
2.06
1.70
1.2
1.4
—
—
—
0
0
(4281824)
22
370
0.59
1.69
1.4
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
105
1328
0.79
1.68
3.3
3.3
u/ml
1105.2
2546.4
0.54
92
1113
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
117
931
1.26
1.68
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
52
367
1.42
1.66
1.5
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
20
112
1.79
1.64
1.4
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
57
410
1.40
1.64
2.2
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
22
366
0.60
1.63
1.0
1.1
u/ml
2.6
3.0
—
8
139
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
30
189
1.59
1.62
1.7
1.8
u/field
2.5
2.0
0.14
18
133
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
47
327
1.44
1.62
1.7
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
32
486
0.66
1.60
1.1
1.1
iu/ml
63.0
56.4
—
7
105
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
98
768
1.28
1.60
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
98
768
1.28
1.60
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
35
230
1.53
1.59
1.9
2.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
225
2614
0.85
1.55
3.8
4.1
%
0.2
0.4
0.35
49
650
(3002523) Influenza virus A Ag [Presence] in Specimen
23
373
0.61
1.55
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
59
795
0.74
1.53
4.4
3.5
mg/l
36.7
27.9
0.68
42
508
(40758292) HTLV I+II Ab panel - Serum
10
44
2.28
1.53
1.0
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
23
371
0.62
1.52
1.0
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
17
296
0.57
1.51
2.8
2.1
e9/l
1.0
1.1
0.15
11
187
(3016879) Cocaine [Presence] in Urine
66
494
1.34
1.51
2.3
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
35
234
1.50
1.49
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
51
367
1.39
1.49
1.6
1.2
u/ml
6.2
3.2
0.85
26
152
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
18
101
1.79
1.48
1.2
1.1
miu/ml
1392.6
1712.4
0.64
18
101
(3007164) IgA [Mass/volume] in Serum or Plasma
521
5708
0.90
1.47
1.5
1.5
g/l
2.7
2.6
0.92
309
3333
(40767503) Oxygen content in Capillary blood by calculation
102
814
1.26
1.46
2.9
2.6
%
15.9
15.9
0.02
52
418
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
254
2212
1.16
1.46
1.7
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
254
0.55
1.45
1.5
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
31
462
0.67
1.44
2.2
2.3
mg/l
32.1
24.7
—
7
118
(3014891) Appearance of Pleural fluid
11
52
2.12
1.44
2.4
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
34
228
1.50
1.43
1.6
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
22
2.73
1.43
1.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
43
303
1.42
1.42
1.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
43
303
1.42
1.42
1.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
43
303
1.42
1.42
1.7
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
188
2197
0.85
1.42
1.2
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
61
806
0.75
1.41
3.0
3.3
u/ml
1859.4
839.6
0.26
56
734
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
17
96
1.77
1.38
1.2
1.4
iu/ml
—
1615592.9
—
0
7
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1113
10522
1.08
1.38
3.4
3.2
u/l
35.2
37.6
0.39
1052
9925
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
23
2.61
1.36
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
46
331
1.39
1.36
1.1
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
21
127
1.66
1.36
1.2
2.5
mg/l
96.2
64.6
0.37
16
84
(3006184) Hemoglobin [Mass/volume] in Capillary blood
103
832
1.24
1.35
2.4
2.2
g/l
129.2
127.5
0.23
73
599
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
22
135
1.63
1.35
1.4
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
393
0.66
1.32
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
92
736
1.26
1.32
1.5
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
28
416
0.67
1.31
1.4
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
34
234
1.46
1.29
1.6
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
47
344
1.37
1.28
2.9
2.5
—
—
—
0
0
(3019977) pH of Arterial blood
31
210
1.48
1.27
1.5
2.6
ph
7.4
7.4
0.40
11
78
(36660697) Celiac disease serology panel - Serum
203
2334
0.86
1.27
1.2
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
8
35
2.29
1.26
1.0
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
18
107
1.69
1.25
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
36
2.22
1.24
1.1
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
314
0.64
1.23
1.4
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
49
2.04
1.22
1.1
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
15
252
0.59
1.21
1.1
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
29
196
1.48
1.21
3.1
3.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
37
2.16
1.21
1.1
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
951
8982
1.08
1.21
2.3
2.3
mg/l
3.3
3.1
1.66
828
7594
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
356
3216
1.12
1.20
1.6
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
140
1184
1.19
1.20
1.3
1.2
u/ml
1.1
0.8
0.15
26
113
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
187
0.53
1.18
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
224
0.58
1.17
1.5
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
164
1410
1.17
1.16
2.1
1.8
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
61
474
1.29
1.14
1.6
1.5
e6/l
2969.8
1873.1
0.45
43
341
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
22
142
1.55
1.14
1.1
1.1
ratio
1.1
1.0
—
8
49
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
177
1535
1.16
1.13
2.2
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
67
528
1.27
1.12
2.3
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
25
167
1.50
1.12
1.6
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
25
167
1.50
1.12
1.6
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
349
3167
1.11
1.10
2.3
2.6
e9/l
73.3
68.5
1.25
266
2390
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
21
2.38
1.09
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
288
3198
0.89
1.09
1.6
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
67
531
1.27
1.08
2.3
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
23
339
0.68
1.07
1.0
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
35
253
1.39
1.06
1.0
1.0
ng/l
345.3
325.0
0.11
21
166
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
35
253
1.39
1.06
1.0
1.0
ng/l
623.5
724.7
0.57
18
162
(3028300) Cannabinoids [Presence] in Urine
67
533
1.26
1.06
2.3
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
54
691
0.78
1.05
3.9
3.6
%
57.2
58.0
0.23
54
691
(3051611) Lipemic interference index of Serum or Plasma
44
331
1.33
1.05
2.8
3.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
82
1.71
1.05
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
55
428
1.29
1.04
1.4
1.4
e6/l
94509.6
87734.1
0.05
32
251
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
416
3824
1.10
1.03
2.6
2.7
umol/l
7.9
9.2
0.72
348
3316
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
46
1.96
1.03
1.3
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
35
255
1.38
1.02
1.0
1.0
ng/l
46.0
45.3
0.02
21
164
(3013650) Neutrophils [#/volume] in Blood by Automated count
1888
19451
0.95
1.01
7.9
9.0
e9/l
4.5
4.2
7.71
1686
16840
(3011985) Renin [Units/volume] in Plasma
55
430
1.28
1.01
1.3
1.4
mu/l
50.3
50.5
0.00
49
377
(3003694) ABO and Rh group [Type] in Blood
806
8512
0.93
0.99
1.3
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
99
829
1.20
0.99
5.2
4.7
mmol/l
3.1
2.8
0.54
60
580
(3015183) Erythrocyte sedimentation rate
7
133
0.53
0.98
1.3
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
65
521
1.25
0.98
2.3
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1667
17220
0.95
0.98
5.7
5.8
e9/l
0.2
0.2
0.37
1482
14893
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
23
2.18
0.98
1.8
2.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
99
830
1.20
0.98
5.2
4.7
kpa
5.1
5.0
0.06
89
814
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
36
1.95
0.97
2.7
2.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
608
6479
0.93
0.96
1.2
1.2
u/ml
1.2
2.1
2.46
180
1635
(44790049)
49
381
1.29
0.95
1.2
1.4
—
—
—
0
0
(44806118)
49
381
1.29
0.95
1.2
1.4
—
—
—
0
0
(44790048)
49
381
1.29
0.95
1.2
1.4
—
—
—
0
0
(44790047)
49
381
1.29
0.95
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1114
10663
1.06
0.95
3.9
3.2
e6/l
50.3
112.2
2.61
907
8223
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
51
1.77
0.94
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
88
733
1.20
0.94
3.3
2.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
85
1.65
0.94
5.1
5.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
303
2758
1.11
0.94
4.6
3.6
ng/l
99.7
91.0
0.81
268
2334
(3025941) Bacteria identified in Stool by Culture
196
1740
1.13
0.94
1.3
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
37
1.89
0.94
2.7
2.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
28
2.14
0.91
1.5
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
220
0.64
0.91
1.5
1.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
21
303
0.69
0.91
2.5
2.2
ml
811.6
628.3
1.13
16
187
(3004588) Protein electrophoresis panel - Serum or Plasma
285
2591
1.11
0.91
2.3
2.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
53
665
0.79
0.91
1.9
1.6
nmol/l
0.8
0.8
0.02
43
554
(3027315) Oxygen [Partial pressure] in Blood
99
837
1.19
0.91
5.2
4.8
kpa
8.5
8.4
0.32
89
820
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
219
0.64
0.90
1.5
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
41
530
0.77
0.90
2.2
3.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
394
0.73
0.89
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
278
0.68
0.89
1.2
1.1
u/ml
7.9
2.4
—
6
103
(3027945) Reticulocytes/100 erythrocytes in Blood
452
4204
1.08
0.89
2.3
2.4
%
1.9
1.8
1.10
411
3672
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
8
42
1.91
0.88
7.3
5.0
ug/min
78.4
62.5
—
8
34
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
127
1.50
0.88
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
25
347
0.72
0.88
1.4
1.2
nmol/l
294.6
342.7
0.71
20
285
(3045414) Leukocytes [Presence] in Urine
133
1526
0.87
0.88
1.8
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
298
1.31
0.87
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
51
405
1.26
0.86
1.3
1.3
pmol/l
228.9
273.5
0.90
39
313
(40758558) Short blood count panel - Blood
897
8559
1.06
0.85
5.9
6.7
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
45
1.78
0.84
1.1
1.2
%
98.5
99.6
—
8
45
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
18
262
0.69
0.83
1.1
1.2
—
3.8
—
0
13
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
57
1.76
0.83
1.5
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
90
762
1.18
0.83
1.6
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
65
1.69
0.82
1.0
1.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
6
32
1.88
0.81
1.2
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
142
1249
1.14
0.81
2.7
3.1
g/l
0.4
0.3
1.09
71
500
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1151
11076
1.05
0.81
2.9
3.0
ng/l
1744.9
1609.9
0.44
1017
9499
(3021960) Folate [Moles/volume] in Serum or Plasma
887
8475
1.06
0.81
1.6
1.6
nmol/l
18.4
20.4
4.17
784
7164
(3023511) Choriogonadotropin [Units/volume] in Urine
24
172
1.40
0.80
1.3
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
11
176
0.62
0.79
1.3
1.4
—
1.5
—
0
10
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
109
943
1.16
0.79
1.5
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
150
0.60
0.78
1.4
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
373
0.75
0.78
3.8
3.6
%
65.8
57.3
1.27
20
226
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
50
618
0.81
0.78
1.4
1.2
miu/ml
229.9
209.3
0.13
19
264
(3006653) Thiamine [Moles/volume] in Blood
23
165
1.40
0.77
1.0
1.2
nmol/l
140.4
136.6
0.11
23
165
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
34
1.77
0.76
1.2
1.2
umol/24h
2.2
1.7
—
6
34
(3019198) Lymphocytes [#/volume] in Blood
1655
17011
0.96
0.76
5.6
5.7
e9/l
1.8
1.9
2.05
1454
14777
(3018095) Leukocytes [#/volume] in Urine
1270
12273
1.05
0.76
4.4
3.7
e6/l
81.2
118.5
1.84
987
8799
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
255
0.70
0.74
1.1
1.1
u/ml
10.4
3.3
—
5
96
(3004716) Salmonella sp identified in Stool by Organism specific culture
156
1392
1.13
0.73
1.4
1.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
16
109
1.47
0.70
1.6
2.0
e6/l
1348.6
22502.1
—
8
61
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
61
729
0.83
0.70
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
28
366
0.76
0.70
5.5
4.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
26
1.92
0.70
1.0
1.2
u/l
5.8
13.9
—
5
26
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
158
0.63
0.70
1.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
46
372
1.24
0.70
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
101
1.49
0.70
1.2
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
41
1.71
0.70
2.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
30
230
1.31
0.69
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
50
409
1.23
0.69
1.6
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
353
3293
1.08
0.68
1.7
1.8
%
1.7
1.5
3.25
307
2852
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
110
1.46
0.68
1.3
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
110
1.46
0.68
1.3
2.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
713
6809
1.06
0.68
2.7
3.1
mmol/l
2.5
2.5
0.03
618
5937
(44806420)
7
118
0.59
0.67
2.1
2.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
120
0.58
0.67
1.6
3.7
%
67.4
53.7
—
7
115
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
5
93
0.54
0.66
2.0
1.5
ug/l
0.3
0.4
—
5
51
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
20
272
0.73
0.66
1.1
1.2
—
64.0
—
0
11
(3004616) Nuclear Ab [Presence] in Serum
32
406
0.79
0.65
1.2
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
111
1.44
0.65
2.9
2.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
53
636
0.83
0.65
5.8
3.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
47
385
1.22
0.65
1.8
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
180
1.34
0.64
1.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
180
1.34
0.64
1.3
1.4
—
—
—
0
0
(4211845)
24
180
1.34
0.64
3.8
3.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
178
1616
1.11
0.64
4.7
3.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
137
1.39
0.64
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2301
23424
0.96
0.64
5.0
4.4
—
—
—
0
0
(4268621)
33
260
1.27
0.63
2.9
2.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
815
7829
1.05
0.63
1.7
1.7
pmol/l
32662303.7
31079386.7
0.03
695
6358
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
200
0.70
0.62
1.4
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
40
491
0.81
0.62
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
16
222
0.72
0.61
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
61
717
0.85
0.61
1.2
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
139
0.65
0.60
1.0
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1627
16658
0.96
0.60
5.5
5.6
e9/l
0.0
0.0
0.45
1426
14191
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
63
736
0.85
0.59
1.9
1.8
iu/l
4.0
5.2
0.57
23
243
(46235355) HIV 1 and 2 tests - Meaningful Use set
398
3756
1.07
0.58
1.8
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
22
166
1.33
0.58
4.0
4.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
7
114
0.61
0.58
1.1
1.7
umol/l
1.9
2.0
—
7
104
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
219
0.73
0.57
1.4
1.5
g/l
1.0
1.0
0.06
16
219
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
39
319
1.22
0.57
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
2389
24266
0.96
0.56
4.1
3.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
87
0.57
0.56
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
88
0.57
0.56
2.4
1.7
—
—
—
0
0
(4024509)
30
374
0.80
0.55
1.6
1.6
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
124
1.37
0.55
2.0
2.1
e6/l
2601.9
667.3
0.44
12
88
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
37
1.62
0.55
3.0
2.8
u/field
0.5
0.5
—
6
37
(3001604) Monocytes [#/volume] in Blood
1620
16563
0.96
0.55
5.5
5.6
e9/l
0.6
0.6
2.44
1418
14103
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
82
1.46
0.54
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
69
791
0.87
0.53
1.9
2.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
338
0.80
0.52
1.4
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
61
705
0.86
0.52
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1123
10916
1.04
0.52
3.2
3.1
mmol/l
7.1
7.3
0.97
971
9073
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
96
0.62
0.52
1.0
1.1
—
—
—
0
0
(4015189)
6
97
0.62
0.52
2.2
2.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
12
83
1.45
0.51
1.7
1.3
%
114.4
111.6
0.20
12
71
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
83
1.45
0.51
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
37
305
1.21
0.51
2.3
1.3
iu/ml
63.8
21.1
—
5
9
(21494814) CD8 cells/100 lymphocytes in Specimen
9
136
0.66
0.51
1.7
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
58
499
1.16
0.51
1.4
1.4
—
—
—
0
0
(44813793)
24
188
1.28
0.51
1.1
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
45
379
1.19
0.51
1.6
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
92
1.41
0.50
1.3
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
432
4111
1.06
0.50
3.5
4.0
u/l
256.2
248.6
0.26
405
3847
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
87
977
0.89
0.50
1.4
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
344
3253
1.06
0.50
3.0
2.8
ng/l
269.1
219.3
1.14
302
2951
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
201
0.75
0.49
6.1
6.4
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
7
45
1.56
0.49
1.9
1.4
%
66.0
76.3
—
7
40
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
133
1455
0.91
0.48
1.7
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
37
441
0.84
0.47
1.9
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
64
560
1.14
0.47
1.6
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
48
1.46
0.46
1.0
1.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
57
495
1.15
0.46
2.0
1.8
%
89.0
89.3
0.15
50
488
(3048689) Calprotectin [Mass/mass] in Stool
335
3531
0.94
0.45
2.2
2.2
ug/g
179.9
148.4
0.61
278
2777
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
81
0.62
0.45
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
135
1237
1.09
0.45
2.7
2.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
287
0.80
0.45
4.0
4.9
u/ml
13.6
53.7
—
5
72
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
84
0.59
0.45
1.2
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
85
0.59
0.45
1.2
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
81
723
1.12
0.44
1.8
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
49
422
1.16
0.44
1.4
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
130
1.31
0.43
2.6
2.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
163
0.74
0.43
1.3
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
18
230
0.78
0.43
1.2
1.3
—
67.3
—
0
22
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
151
0.73
0.42
1.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
92
0.65
0.42
1.2
1.7
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
36.0
—
0
6
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
2.0
—
0
8
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
1.6
—
0
8
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
3.2
—
0
7
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
2.5
—
0
8
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
3.9
—
0
7
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
1.3
—
0
8
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
0.7
—
0
7
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
3.9
—
0
7
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
4.4
—
0
6
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.2
—
0
9
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
287
3026
0.94
0.41
4.6
4.0
mmol/l
1.2
1.2
1.29
244
2610
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
17
0.00
0.40
0.0
1.3
—
4133.8
—
0
10
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.5
—
3.0
—
0
8
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
175
1874
0.93
0.40
1.2
1.3
au/ml
59.8
50.0
—
9
78
(3024263) Appearance of Synovial fluid
16
205
0.78
0.40
1.3
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
22
177
1.24
0.40
2.0
1.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
20
249
0.80
0.40
1.9
2.2
mmol/l
7.4
6.9
0.33
15
157
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
149
0.74
0.40
12.5
12.9
nmol/l
640.5
842.9
1.24
11
142
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
193
0.78
0.39
2.9
4.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
226
0.80
0.39
1.5
1.5
u/l
5.6
7.1
—
7
104
(4133840)
11
80
1.38
0.38
1.3
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
159
0.75
0.38
1.3
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
67
1.34
0.38
1.2
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
89
809
1.10
0.38
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
168
1795
0.93
0.37
1.2
1.3
u/ml
384.8
192.4
0.48
154
1639
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
188
1.22
0.37
1.1
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
37
1.35
0.37
8.2
11.4
mmol/l
3.6
5.7
—
5
37
(3021788) Differential panel - Synovial fluid
57
641
0.89
0.37
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
158
0.76
0.37
1.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
150
1608
0.93
0.37
1.7
1.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
72
1.39
0.36
4.4
7.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
347
3321
1.05
0.36
2.1
2.1
g/l
0.2
0.2
0.14
323
3068
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
11
146
0.75
0.36
1.3
1.6
nmol/l
20.1
7.7
0.29
11
120
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
52
460
1.13
0.35
2.0
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1083
10599
1.03
0.35
3.3
3.2
mg/l
232.3
329.8
0.48
736
6611
(3005570) Glucose [Moles/volume] in Urine
41
357
1.15
0.35
1.9
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
48
423
1.14
0.35
1.3
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
15
189
0.79
0.34
1.9
2.7
%
35.7
39.1
—
6
66
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
265
0.83
0.34
2.2
2.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
82
1.34
0.34
4.1
7.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2770
27451
1.03
0.34
26.0
19.6
g/l
331.5
331.8
1.20
2734
27191
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
196
2073
0.94
0.33
2.1
2.4
au/ml
38.3
24.7
—
6
90
(3037522) Nuclear Ab [Titer] in Serum
396
4113
0.96
0.33
1.4
1.3
titre
494.3
525.6
0.13
92
874
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
44
499
0.88
0.33
1.2
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
23
191
1.21
0.33
1.1
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
41
359
1.14
0.33
1.7
1.4
mmol/l
6.1
6.2
0.12
41
335
(3045142) Bone marrow Pathology biopsy report
35
403
0.87
0.33
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
87
0.69
0.33
1.0
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
88
0.68
0.33
1.2
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
89
0.67
0.33
1.3
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
575
5580
1.04
0.32
2.9
2.4
umol/l
12.2
12.6
0.46
525
5119
(3014148) Varicella zoster virus Ab [Titer] in Serum
31
266
1.17
0.32
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
60
540
1.11
0.32
1.7
1.5
g/l
31.3
32.4
0.28
53
485
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
33
285
1.16
0.32
1.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
187
0.80
0.32
1.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
92
1.31
0.31
1.2
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
15
119
1.26
0.31
40.7
32.9
ug/l
7.7
7.3
0.27
15
109
(3033799) Differential panel - Peritoneal fluid
14
110
1.27
0.31
2.0
2.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
91
838
1.09
0.31
3.6
3.1
nmol/l
0.8
0.8
0.61
76
626
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
358
0.86
0.31
1.2
1.1
u/l
40.9
57.0
2.33
19
237
(3000570) Elastase.pancreatic [Mass/mass] in Stool
94
1016
0.92
0.30
1.4
1.4
ug/g
305.8
276.2
0.67
58
611
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
54
1.30
0.30
1.4
1.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
31
357
0.87
0.30
1.2
1.2
mmol/l
7.3
7.5
0.12
23
254
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
79
859
0.92
0.29
1.3
1.2
u/ml
60.5
44.2
—
5
46
(3023323) Follitropin [Units/volume] in Serum or Plasma
93
861
1.08
0.29
1.5
1.3
iu/l
32.3
34.4
0.23
74
740
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
18
148
1.22
0.29
1.7
2.5
u/ml
991.1
1163.7
0.16
18
148
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
37
418
0.88
0.28
1.2
1.1
u/ml
0.3
1.7
—
9
165
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
61
669
0.91
0.28
1.2
1.2
u/ml
1.8
6.8
—
9
45
(3021387) Prolactin [Units/volume] in Serum or Plasma
69
632
1.09
0.28
1.9
1.7
mu/l
279.3
308.4
0.49
61
585
(3032057) Clostridioides difficile [Presence] in Stool
11
85
1.29
0.28
1.7
2.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
11
85
1.29
0.28
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
25
214
1.17
0.27
1.8
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
63
1.27
0.27
1.1
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
63
1.27
0.27
1.3
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
18
149
1.21
0.27
1.0
1.1
u/l
1.2
1.1
—
9
78
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
571
5560
1.03
0.27
3.2
3.0
e6/l
3.0
2.3
0.71
333
3027
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
194
0.82
0.27
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
194
0.82
0.27
1.2
1.4
—
—
—
0
0
(4306422)
41
365
1.12
0.27
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
82
886
0.92
0.27
1.5
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
49
543
0.90
0.27
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
75
813
0.92
0.27
1.3
1.2
u/ml
4.1
6.9
0.70
19
130
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
74
802
0.92
0.27
1.3
1.2
u/ml
3.9
6.7
0.28
11
78
(3005988) Vibrio sp identified in Specimen by Organism specific culture
39
437
0.89
0.26
1.9
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
23
268
0.86
0.26
1.4
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
193
0.83
0.26
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
193
0.83
0.26
1.2
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
147
1391
1.06
0.26
5.1
3.8
mmol/l
25.2
24.9
0.56
136
1268
(3025130) Human papilloma virus identified in Specimen
25
289
0.86
0.26
1.7
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
95
886
1.07
0.26
2.4
2.3
ug/min
148.3
108.3
0.34
56
513
(3008536) Aspergillus sp Ab [Presence] in Serum
5
72
0.69
0.26
4.2
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
77
1.30
0.26
1.1
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
64
587
1.09
0.26
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
383
3952
0.97
0.25
1.6
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
99
926
1.07
0.25
1.5
1.6
iu/ml
0.1
12.9
0.90
31
195
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
44
487
0.90
0.25
1.3
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
35
311
1.13
0.25
1.7
2.2
u/field
3.4
1.6
0.66
18
113
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
39
434
0.90
0.24
1.9
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
39
434
0.90
0.24
1.9
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
255
0.86
0.24
1.1
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
10
126
0.79
0.24
1.3
1.4
—
—
—
0
0
(4027681)
18
152
1.18
0.23
1.1
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
44
485
0.91
0.23
2.3
2.5
mmol/l
105.7
105.4
0.21
44
479
(3041354) Potassium [Moles/volume] in Venous blood
44
485
0.91
0.23
2.3
2.5
mmol/l
4.1
4.1
0.19
44
479
(3005011) Chlamydia sp Ab [Titer] in Serum
5
38
1.32
0.23
1.6
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
42
380
1.11
0.23
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
45
409
1.10
0.22
1.5
1.3
nmol/l
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
43
473
0.91
0.22
2.4
2.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
7
93
0.75
0.22
1.9
2.3
nmol/l
154.9
152.4
—
7
83
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
497
4851
1.03
0.22
3.0
2.5
%
22.8
22.2
0.29
404
4078
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
95
0.74
0.22
1.4
2.3
ug/l
1.3
1.3
—
7
89
(3007566) Smooth muscle Ab [Titer] in Serum
89
835
1.07
0.22
1.3
1.2
titre
62.9
94.7
—
7
62
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1459
14764
0.98
0.22
2.0
2.0
pmol/l
89.9
94.4
3.53
776
7518
(40760892) CBC W Ordered Manual Differential panel - Blood
716
7023
1.02
0.22
4.3
4.5
—
—
—
0
0
(4212803)
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
10
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
21
182
1.15
0.21
1.0
1.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
201
1.15
0.21
1.3
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
103
0.78
0.21
1.1
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
529
5174
1.03
0.21
2.9
2.4
g/l
2.3
2.3
0.57
483
4754
(3041672) Baker's yeast Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
12.9
—
0
13
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
25
282
0.89
0.20
1.2
1.5
u/ml
26.7
21.9
—
7
59
(3009214) Lutropin [Units/volume] in Serum or Plasma
62
577
1.08
0.20
1.4
1.3
u/l
9.3
10.5
0.24
48
469
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
18
155
1.16
0.19
1.2
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
119
1133
1.05
0.19
2.2
2.1
g/l
37.0
37.4
0.26
98
955
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
137
1432
0.96
0.19
1.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
41
447
0.92
0.19
1.9
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
249
0.88
0.19
1.1
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
327
3183
1.03
0.19
2.9
2.4
u/l
43.5
52.9
0.20
283
2714
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
40
436
0.92
0.18
1.8
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
58
1.21
0.18
4.3
7.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
147
1.16
0.18
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
222
2291
0.97
0.17
3.0
3.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
61
651
0.94
0.17
1.6
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
177
1834
0.96
0.17
3.0
3.1
pmol/l
4.5
4.4
0.20
160
1597
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
142
0.84
0.17
1.2
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
27
243
1.11
0.17
1.9
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
67
0.75
0.17
2.2
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
23
205
1.12
0.17
1.2
1.2
mmol/l
7.8
12.1
—
6
60
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
129
1.16
0.17
1.4
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
215
0.88
0.16
1.6
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
120
0.83
0.16
1.4
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
69
1.16
0.16
5.3
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
139
1337
1.04
0.16
1.5
1.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
27
298
0.91
0.16
1.2
1.8
mg/l
4.0
4.6
0.47
27
281
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
30
273
1.10
0.16
1.7
1.9
%
10.4
10.9
0.27
30
273
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
72
760
0.95
0.15
1.6
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
87
829
1.05
0.15
1.6
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
80
841
0.95
0.15
1.8
1.9
mg/l
10.8
12.0
0.54
73
773
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
138
1331
1.04
0.15
1.6
1.9
u/l
38.6
39.1
0.09
117
1169
(3039162) Centromere protein B Ab [Units/volume] in Serum
41
381
1.08
0.14
1.3
1.2
u/ml
42.8
32.2
—
7
22
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
118
0.85
0.14
1.6
2.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
44
412
1.07
0.13
1.6
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
1355
1.03
0.13
2.1
2.3
g/l
3.1
3.1
0.01
106
1052
(3037556) Urate [Mass/volume] in Serum or Plasma
9
109
0.83
0.13
1.0
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
67
638
1.05
0.12
5.8
4.9
iu/ml
1331.9
2892.5
0.27
11
94
(3029634) Reagin Ab [Titer] in Serum by VDRL
33
355
0.93
0.12
1.8
2.0
—
2.8
—
0
8
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
11
127
0.87
0.12
1.1
1.6
umol/l
29.7
29.7
0.00
11
122
(3003327) Ova and parasites identified in Stool by Light microscopy
89
926
0.96
0.12
1.6
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
57
600
0.95
0.12
1.3
1.2
u/ml
67.4
47.5
—
8
64
(3035947) Staphylolysin Ab [Units/volume] in Serum
17
152
1.12
0.12
1.2
1.2
—
4.1
—
0
8
(3026493) Urate [Moles/volume] in Serum or Plasma
911
9200
0.99
0.12
2.7
2.7
umol/l
4080.2
5720.5
0.60
788
7860
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
19
172
1.11
0.11
1.3
1.1
u/l
81.9
82.6
0.02
14
133
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
19
172
1.11
0.11
1.3
1.1
u/l
34.3
25.1
0.28
11
133
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
19
172
1.11
0.11
1.6
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
23
211
1.09
0.11
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
23
211
1.09
0.11
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
23
211
1.09
0.11
1.2
1.2
—
—
—
0
0
(3036603) Volume of Urine
19
208
0.91
0.10
1.6
1.7
ml
1888.8
1697.8
—
6
52
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
96
1.15
0.10
1.3
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1128
11196
1.01
0.10
3.9
4.0
mg/mmol
14.5
8.7
2.33
748
7021
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
45
1.11
0.09
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
31
330
0.94
0.09
1.3
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
87
1.15
0.09
1.2
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
47
493
0.95
0.09
1.6
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
194
1901
1.02
0.09
1.5
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
20
216
0.93
0.08
1.3
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1221
12137
1.01
0.08
2.7
3.4
mmol/l
2.3
2.4
1.86
1047
10425
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
23
214
1.08
0.08
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
23
214
1.08
0.08
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
23
214
1.08
0.08
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
64
0.78
0.08
1.2
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
78
805
0.97
0.08
1.4
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
31
328
0.94
0.08
1.1
1.1
—
2.9
—
0
5
(3002619) Bacteria identified in Specimen by Culture
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
84
865
0.97
0.08
3.7
3.0
mg/l
1.8
1.6
0.91
78
773
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
53
551
0.96
0.08
1.2
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
51
490
1.04
0.07
1.3
1.2
u/ml
265.3
292.9
0.30
32
300
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
1371
1.02
0.07
2.0
2.3
g/l
9.8
10.3
0.69
111
1146
(3000034) Microalbumin [Mass/volume] in Urine
34
323
1.05
0.07
2.6
3.1
mg/l
17.3
31.4
1.03
24
243
(3001186) Copper [Moles/volume] in Serum or Plasma
8
75
1.07
0.07
1.3
1.2
umol/l
17.7
16.7
—
8
66
(40768441) Liver Pathology biopsy report
25
235
1.06
0.07
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
85
827
1.03
0.07
5.7
4.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
84
0.83
0.07
1.3
2.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
89
1.12
0.06
2.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
89
1.12
0.06
2.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
89
1.12
0.06
2.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
89
1.12
0.06
2.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
94
0.85
0.06
1.1
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
127
1245
1.02
0.06
2.9
3.4
mg/l
57.0
107.0
0.55
108
1004
(3005719) IgG [Mass/volume] in Serum or Plasma
243
2398
1.01
0.06
2.4
2.8
g/l
11.0
10.5
0.84
219
2175
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
21
197
1.07
0.06
1.0
1.0
mg/l
305.0
282.4
0.19
21
171
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
40
416
0.96
0.06
1.5
1.5
%
59.3
59.6
0.02
30
255
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
18
168
1.07
0.06
2.3
3.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
294
0.95
0.06
1.4
1.4
g/l
3.1
2.9
0.18
22
207
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
294
0.95
0.06
1.4
1.4
g/l
0.5
0.4
0.42
22
207
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
294
0.95
0.06
1.4
1.4
g/l
7.3
6.8
0.34
22
205
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
90
1.11
0.05
2.2
1.4
ug/l
13.1
8.9
—
10
90
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
34
326
1.04
0.05
1.3
1.5
%
24.6
28.4
0.28
24
194
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
33
344
0.96
0.05
1.2
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
37
356
1.04
0.05
1.1
1.1
u/ml
2.9
2.9
0.01
12
167
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62
636
0.97
0.05
1.6
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
120
0.92
0.05
1.3
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
101
992
1.02
0.04
2.1
2.2
g/l
0.0
0.0
0.00
88
909
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
199
1.06
0.04
1.3
1.3
u/ml
2.9
1.5
0.19
12
100
(3024932) HLA-DR beta [Type]
10
91
1.10
0.04
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
109
1074
1.02
0.04
2.2
2.2
g/l
0.0
0.1
0.90
95
973
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
55
563
0.98
0.03
1.5
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
126
1244
1.01
0.03
2.9
3.4
mg/l
42.2
62.7
0.91
108
1006
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
47
482
0.97
0.03
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
87
884
0.98
0.03
1.6
1.6
e6/l
24608.9
13585.3
1.08
70
628
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
148
1464
1.01
0.03
2.0
2.3
g/l
7.5
7.4
0.09
107
1071
(3034891) Synovial lining cells/100 cells in Synovial fluid
17
161
1.06
0.03
1.4
1.4
%
4.6
3.7
—
5
35
(3004451) EKG impression Narrative
18
189
0.95
0.03
1.3
1.3
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
11
118
0.93
0.02
1.6
1.5
%
36.9
18.3
1.10
11
108
(3044927) Protein electrophoresis panel - Urine
39
400
0.97
0.02
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
24
249
0.96
0.02
1.3
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
13
138
0.94
0.02
1.8
1.5
ug/l
35.8
8.7
0.48
13
118
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
102
1008
1.01
0.02
2.1
2.2
g/l
0.0
0.0
0.49
88
911
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
55
560
0.98
0.02
1.5
1.4
—
17.7
—
0
13
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
125
1239
1.01
0.02
2.6
2.4
g/l
0.5
1.1
2.20
104
1047
(3024471) HLA-A [Type]
10
93
1.08
0.02
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
52
529
0.98
0.02
1.3
1.2
—
—
—
0
0
(4010399)
244
2428
1.01
0.01
1.5
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
14
147
0.95
0.01
1.4
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
381
3797
1.00
0.01
4.0
3.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
51
502
1.02
0.01
1.3
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
1462
1.01
0.01
2.0
2.3
g/l
3.9
3.8
0.15
105
1028
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
1463
1.00
0.00
2.0
2.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
189
1897
1.00
0.00
1.7
2.0
g/l
1.1
1.5
3.51
164
1700
(3000012) Reticulocyte production index
22
219
1.00
0.00
1.2
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
195
0.97
0.00
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
48
477
1.01
0.00
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
37
375
0.99
0.00
3.6
3.6
—
—
—
0
0
(4062490)
29
295
0.98
0.00
1.4
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
46
463
0.99
0.00
1.9
1.5
g/l
0.6
0.8
0.66
40
349
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
62
615
1.01
0.00
1.2
1.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
16
156
1.03
0.00
1.1
1.5
umol/l
21.5
21.4
0.00
16
148
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
138
1.01
0.00
2.9
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
11
110
1.00
0.00
1.9
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
100
1.00
0.00
2.3
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
18
179
1.01
0.00
2.5
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
18
179
1.01
0.00
2.5
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
18
179
1.01
0.00
2.5
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
18
179
1.01
0.00
2.5
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
49
495
0.99
0.00
1.5
1.4
u/ml
111.0
121.6
—
9
101
(3008401) Mugwort IgE Ab [Units/volume] in Serum
35
347
1.01
0.00
1.1
1.1
u/ml
0.4
1.1
—
10
142
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
180
1.00
0.00
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
180
1.00
0.00
1.1
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
31
308
1.01
0.00
1.6
1.8
—
946.7
—
0
12
(3049717) Cytology report of Urine Cyto stain
147
1471
1.00
0.00
2.7
2.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
28
281
1.00
0.00
1.2
1.4
u/l
42.0
32.1
0.75
23
225
(40760888) Immunoglobulin light chains.free panel - Serum
94
942
1.00
0.00
2.8
3.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
81
809
1.00
0.00
1.6
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
22
222
0.99
0.00
1.6
2.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
126
1.03
0.00
1.6
1.8
ug/l
37.6
80.7
0.31
13
116
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
125
1.04
0.00
1.1
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
87
865
1.01
0.00
1.5
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
121
1212
1.00
0.00
2.8
3.4
ratio
4.8
1.9
0.40
13
83
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
136
1.03
0.00
2.9
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
136
1.03
0.00
2.9
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
50
505
0.99
0.00
1.1
1.1
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
2.0
—
0
8
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
2.1
—
0
8
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
11.2
—
0
6
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
62
0.97
0.00
1.0
1.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
81
0.99
0.00
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
58
0.86
0.00
1.0
1.2
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
36.0
—
0
5
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.4
—
0
5
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
65
0.92
0.00
2.0
3.0
—
55.5
—
0
13
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
68
0.88
0.00
1.5
1.6
ng/l
88.0
147.7
—
6
68
(3022689) Creatine [Moles/volume] in Urine
9
94
0.96
0.00
1.4
1.5
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_SAH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_SAH | 2.296 [2.07, 2.55] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.376 |
During the follow-up period (1.1.1998 — 31.12.2019), 2845 out of 9406 females with I9_SAH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_SAH | 2.236 [2.01, 2.49] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.022 |
During the follow-up period (1.1.1998 — 31.12.2019), 2937 out of 8674 males with I9_SAH died.
Mortality risk
Mortality risk for people of age
years, who have I9_SAH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.181% | 0.502% |
| 5 | 1.169% | 2.812% |
| 10 | 3.511% | 6.629% |
| 15 | 6.527% | 12.855% |
| 20 | 11.833% | 21.177% |
Relationships between endpoints
↥Index endpoint: I9_SAH – Subarachnoid haemorrhage
GWS hits: 5
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data